左主干支架 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Expansion or contraction of stenting in coronary artery disease?
Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial
Differences between the left main and other bifurcations
New-onset atrial fibrillation after PCI and CABG for left main disease: insights from the EXCEL trial and additional studies
Impact of Lesion Preparation Strategies on Outcomes of Left Main PCI: The EXCEL Trial
Intravascular Imaging and 12-Month Mortality After Unprotected Left Main Stem PCI: An Analysis From the British Cardiovascular Intervention Society Database
Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial
Contemporary Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in the United States: An Analysis of the National Cardiovascular Data Registry Research to Practice Initiative
Long-Term Outcomes After PCI or CABG for Left Main Coronary Artery Disease According to Lesion Location
Bayesian Interpretation of the EXCEL Trial and Other Randomized Clinical Trials of Left Main Coronary Artery Revascularization

|<<... 3 4 5 6 7 8 9 ...>>|

Editorial

2019 Oct 12;394(10206):1299-1300.

JOURNAL：Lancet.

Article Link

Expansion or contraction of stenting in coronary artery disease?

Taggart DP, Pagano D.

3959

Keywords: PCI vs CABG; left main

ABSTRACT

In the past four decades, more than 20 trials of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) have tested whether iterative technical advances in PCI have made it as effective as CABG in patients with stable coronary artery disease. The clinical relevance of most of these trials to real-world practice has, however, been plagued by three issues.

First, by largely enrolling highly selected patients with low-severity coronary artery disease, the trials were inherently biased towards more favourable outcomes for PCI. Second, by limiting follow-up to a few years, the trials hid the accelerating divergence in survival benefit of CABG. Third, even in relatively contemporary trials, surgical patients received substantially inferior medical therapy, thereby mitigating the overall benefits of CABG.